Kazuo Orita

Title: Kazuo Orita: Innovator in Pharmaceutical Chemistry

Introduction

Kazuo Orita is a notable inventor based in Saitama, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that serve as DPP-IV inhibitors. With a total of 4 patents to his name, Orita's work has had a meaningful impact on drug development.

Latest Patents

One of his latest patents is a method for producing an aminoacetylpyrrolidinecarbonitrile derivative. This method aims to provide an efficient way to produce a compound that is useful as a DPP-IV inhibitor. The process involves allowing an acid to act on an aminoacetylpyrrolidinecarboxamide derivative, followed by the action of a dehydrating agent.

Another significant patent involves the preparation of stable crystals of a substituted phenylpropionic acid derivative. This patent details a process for producing (S)-2-[[3-[N-[4-[(4-fluorophenoxy)phenyl]methyl]carbamoyl]-4-methoxyphenyl]methyl]butanoic acid on an industrial scale. The invention focuses on finding homogeneous and stable crystals, which are characterized by specific diffraction angles in X-ray powder diffraction.

Career Highlights

Kazuo Orita is currently associated with Kyorin Pharmaceutical Co., Ltd., where he continues to innovate in the field of pharmaceuticals. His work has been instrumental in advancing methods for producing important pharmaceutical compounds.

Collaborations

Orita has collaborated with notable coworkers such as Michiro Ohnota and Tomomi Koike. Their combined expertise has contributed to the successful development of various pharmaceutical innovations.

Conclusion

Kazuo Orita's contributions to pharmaceutical chemistry exemplify the importance of innovation in drug development. His patents reflect a commitment to improving methods for producing vital compounds, thereby enhancing therapeutic options for patients.